AI assistant
Sending…
Genpact LTD — Director's Dealing 2023
May 9, 2023
30790_dirs_2023-05-09_074f18b5-2079-45dc-aba8-a012d92662a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Genpact LTD (G)
CIK: 0001398659
Period of Report: 2023-05-05
Reporting Person: White Heather (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-05 | Common Shares | M | 12500 | $31.5 | Acquired | 53345 | Direct |
| 2023-05-05 | Common Shares | S | 12500 | $40.7239 | Disposed | 40845 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-05 | Employee Stock Option (Right to Buy) | $31.5 | M | 12500 | Disposed | 2028-04-01 | Common Shares (12500) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023.
F2: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.49 to $41.03. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3: The option vested 50% on April 2, 2021 and the remainder on April 2, 2023.
More from Genpact LTD
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 5
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3